Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease.
Park S, Park CW, Eom JH, Jo MY, Hur HJ, Choi SK, Lee JS, Nam ST, Jo KS, Oh YW, Lee J, Kim S, Kim DH, Park CY, Kim SJ, Lee HY, Cho MS, Kim DS, Kim DW.
Park S, et al. Among authors: eom jh.
Cell Stem Cell. 2024 Feb 1;31(2):278-279. doi: 10.1016/j.stem.2024.01.006.
Cell Stem Cell. 2024.
PMID: 38306996
Free article.
No abstract available.